Trial intelligence / Profile preview

Lidocaine Patch for Mechanical Neck Pain

NCT04378959Completed

Sponsor
Johns Hopkins University
Start
Feb 2021
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in Cervicalgia (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Mean reduction in average neck pain score on 0-10 numerical rating scale at 4 weeks. Started Feb 2021; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

Cervicalgia

Beyond the preview

Go deeper on NCT04378959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04378959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call